These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5752992)

  • 21. Bovine serum prolactin, growth hormone, cortisol and milk yield after ergocryptine.
    Smith VG; Beck TW; Convey EM; Tucker HA
    Neuroendocrinology; 1974; 15(3-4):172-81. PubMed ID: 4472947
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of lactation in mice following feeding with ergot sclerotia [Claviceps fusiformis (Loveless)] from the bulrush millet [Pennisetum typhoides (Staph and Hubbard)] and an alkaloid component.
    Mantle PG
    Proc R Soc Lond B Biol Sci; 1968 Jul; 170(1021):423-34. PubMed ID: 4385587
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibition of puerperal lactation with ergot alkaloids].
    Varga L; Luttierbeck PM; Pryor JS; Wenner R; Erb H
    Schweiz Med Wochenschr; 1972 Sep; 102(36):1284-5. PubMed ID: 5054638
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of 2-Br-alpha-ergocryptine on serum levels of prolactin and the estrous cycle in sheep.
    Niswender GD
    Endocrinology; 1974 Feb; 94(2):612-5. PubMed ID: 4855722
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of 2-Br- -ergocryptine on plasma prolactin level and milk yield in cows.
    Karg H; Schams D; Reinhardt V
    Experientia; 1972 May; 28(5):574-6. PubMed ID: 4557302
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum FSH rise induced by CB-154 (2-Br-alpha-ergocryptine) in postpartum women.
    Seki K; Seki M; Okumura T
    J Clin Endocrinol Metab; 1974 Jul; 39(1):184-6. PubMed ID: 4858181
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of ergotamine on milk-ejection in lactating rat.
    GROSVENOR CE
    Proc Soc Exp Biol Med; 1956 Feb; 91(2):294-6. PubMed ID: 13297781
    [No Abstract]   [Full Text] [Related]  

  • 28. Ergotamine, oxytocin and milk let-down in lactating rat.
    GROSVENOR CE; TURNER CW
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):466-8. PubMed ID: 13389492
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 30. The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
    Del Pozo E; Del Re RB; Varga L; Friesen H
    J Clin Endocrinol Metab; 1972 Nov; 35(5):768-71. PubMed ID: 4672297
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolactin inhibition and suppression of puerperal lactation by a Br-erocryptine (CB 154). A comparison with estrogen.
    Brun del Re R; Del Pozo E; De Grandi P; Friesen H; Hinselmann M; Wyss H
    Obstet Gynecol; 1973 Jun; 41(6):884-90. PubMed ID: 4708482
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence for a physiological role of prolactin in osmoregulation in the rat after its inhibition by 2-bromo- -ergokryptine.
    Richardson BP
    Br J Pharmacol; 1973 Mar; 47(3):623P-624P. PubMed ID: 4730843
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 2-BR-alpha-ergokryptine (CB 154) on sex-linked rejection of pituitary isografts in female C57BL mice.
    Hoshino K
    Experientia; 1973; 29(7):882-4. PubMed ID: 4146807
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct inhibition of pituitary LH secretion in rats by CB-154 (2-Br-alpha-ergocryptine).
    Seki M; Seki K; Yoshihara T; Watanabe N; Okumura T
    Endocrinology; 1974 Mar; 94(3):911-4. PubMed ID: 4591828
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agent.
    Johnson AM; Vigouret JM; Loew DM
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R40. PubMed ID: 4276573
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrous cycle of mouse with subcutaneous pellet implant of ergocornine and 2-Br-alpha-ergokryptin.
    Nagasawa H; Yanai R
    Endocrinol Jpn; 1970 Jun; 17(3):233-5. PubMed ID: 5535943
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.
    Sinha YN; Salocks CB; Lewis UJ; VanderLaan WP
    Endocrinology; 1974 Oct; 95(4):947-54. PubMed ID: 4472149
    [No Abstract]   [Full Text] [Related]  

  • 38. Changes in plasma growth hormone levels in normal and acromegalic subjects following administration of 2-bromo-alpha-ergocryptine.
    Camanni F; Massara F; Belforte L; Molinatti GM
    J Clin Endocrinol Metab; 1975 Mar; 40(3):363-6. PubMed ID: 1117050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodology in premature pregnancy termination. I.
    Wentz AC; Burnett LS; King TM
    Obstet Gynecol Surv; 1973 Jan; 28(1):2-19. PubMed ID: 4614143
    [No Abstract]   [Full Text] [Related]  

  • 40. A new approach to the inhibition of puerperal lactation.
    Rolland R; Schellekens L
    J Obstet Gynaecol Br Commonw; 1973 Nov; 80(11):945-51. PubMed ID: 4800555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.